Studies suggest rates of infection are still much higher in the unvaccinated and that vaccination still offers strong protection against severe illness, hospitalization and death, the key reasons for getting a shot.
Though pessimistic about a return to pre-pandemic life, a majority of Americans reported dining out, socializing and visiting retail stores in the last week.
A late-stage trial showed the pill, which Merck is developing with Miami-based Ridgeback Therapeutics, halves the chances of hospitalization or death in recently diagnosed patients at risk of severe illness.